Noosa News
Brisbane company wins European approval for rapid COVID-19 tests
A Brisbane-based firm has won approval from European regulators to sell its 15-minute COVID-19 rapid test.
The company, AnteoTech, has been given the Conformitè Europëenne Mark registration for its antigen rapid test, EuGeni.
AnteoTech chief executive Derek Thomson.
The reusable test, which now meets crucial health and safety conditions in Europe and the United Kingdom, is expected to be used in mass testing programs such as concerts and sporting events.
The tests have not been approved for use in Australia.
AnteoTech chief executive Derek Thomson said he was “leverage opportunities that lie ahead of us”.
“CE Mark registration for the COVID-19 antigen rapid test platform provides AnteoTech with an opportunity to capture some of the…
-
Noosa News22 hours agoPolice make emergency declaration after fire at storage facility north of Brisbane
-
General23 hours agoTassie heads to the polls as the Liberals leave the building
-
General19 hours agoSyria orders women to wear burkinis on public beaches, while Western-style swimwear allowed in luxury hotels
-
Noosa News11 hours agoBrisbane news LIVE updates: Burpengary storage facility engulfed in fire | Toll road laws passed in Parliament